Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus

Antiviral Research

Volumn 61, Issue 2, 2004, Pages 133-137

  Aquaro, Stefano ^a   Guenci, Tania ^a   Di Santo, Fabiola ^a   Francesconi, Mauro ^b   Caliò, Raffaele ^a   Perno, Carlo Federico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Frascati Hospital   (Italy)

Author keywords

CD4 lymphocytes; HAART; Protease inhibitors; Reservoirs; Therapy

Indexed keywords

AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN P24; GAG PROTEIN; PROTEINASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SUPERNATANT; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0344736982     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2003.09.002     Document Type: Article

References (29)

1. Aquaro S., Perno C.F., Balestra E., Balzarini J., Cenci A., Francesconi M., Panti S., Serra F., Villani N., Caliò R. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. J. Leukoc. Biol. 62:1997a;138-143.
2. Aquaro S., Balestra E., Cenci A., Francesconi M., Caliò R., Perno C.F. HIV infection in macrophage: role of long life cells and related therapeutical strategies. J. Biol. Regul. Homeost. Agents. 11:1997b;69-73.
3. Aquaro S., Panti S., Caroleo M.C., Balestra E., Cenci A., Forbici F., Ippolito G., Mastino A., Testi R., Mollace V., Caliò R., Perno C.F. Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes. J. Leukoc. Biol. 68:2000a;429-435.
4. Aquaro S., Wedgwood O., Yarnold C., Cahard D., Pathinara R., McGuigan C., Caliò R., De Clercq E., Balzarini J., Perno C.F. Activity of masked 2′-3′-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages. Antimicrob. Agents Chemother. 44:2000b;173-177.
5. Aquaro S., Bagnarelli P., Guenci T., De Luca A., Clementi M., Balestra E., Caliò R., Perno C.F. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. J. Med. Virol. 68:2002;479-488.
6. Badley A.D., Dockrell D., Simpson M., Schut R., Lynch D.H., Leibson P., Paya C.V. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185:1997;55-64.
7. Cenci A., Perno C.F., Menzo S., Clementi M., Erba F., Tavazzi B., Di Pierro D., Aquaro S., Caliò R. Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL. AIDS Res. Hum. Retroviruses. 13:1997;629-632.
8. Crowe S.M., McGrath M.S., Elbeik T., Kirihara J., Mills J. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus. J. Med. Virol. 29:1989;176-180.
9. Crowe S.M., Mills J., Kirihara J., Boothman J., Marshall J.A., McGrath M.S. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells. AIDS Res. Hum. Retroviruses. 6:1990;1031-1037.
10. Hatano H., Vogel S., Yoder C., Metcalf J.A., Dewar R., Davey R.T. Jr., Polis M.A. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS. 14:2000;1357-1363.
11. Herbein G., Mahlknecht U., Batliwalla F., Gregersen P., Pappas T., Butler J., O'Brien W.A., Verdin E. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature. 395:1998;189-194.
12. Igarashi T., Brown C.R., Endo Y., Buckler-White A., Plishka R., Bischofberger N., Hirsch V., Martin M.A. Macrophages are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. U.S.A. 98:2001;658-663.
13. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeshkpour G.H., Yungbluth M., Janotta F., Aksamit A., Martin M.A., Fauci A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
14. Lipton S.A., Gendelman H.E. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:1995;934-940.
15. Mastino A., Grelli S., Piacentini M., Oliverio S., Favalli C., Perno C.F., Garci E. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell. Immunol. 152:1993;120-130.
16. McQuade T.J., Tomasselli A.G., Liu L., Karacostas V., Moss B., Sawyer T.K., Heinrikson R.L., Tarpley W.G. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science. 247:1990;454-456.
17. Meek T.D., Lambert D.M., Dreyer G.B., Carr T.J., Tomaszek T.A. Jr., Moore M.L., Strickler J.E., Debouck C., Hyland L.J., Matthews T.J. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature. 343:1990;90-92.
18. Meltzer M.S., Nakamura M., Hansen B.D., Turpin J.A., Kalter D.C., Gendelman H.E. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res. Hum. Retroviruses. 6:1990;967-971.
19. Mollace V., Salvemini D., Riley D.P., Muscoli C., Inaccone M., Granato T., Masuelli L., Modesti A., Rotiroti D., Nisticò R., Bertoli A., Perno C.F., Aquaro S. The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages. J. Leukoc. Biol. 71:2002;65-72.
20. Orenstein J.M., Fox C., Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science. 276:1997;1857-1861.
21. Perno, C.F., Yarchoan, R., 1993. Culture of HIV in monocytes and macrophages. Curr. Protocols Immunol., John Wiley and Sons, New York, 12.4.1-12.4.11.
22. Perno C.F., Yarchoan R., Cooney D.A., Hartman N.R., Gartner S., Popovic M., Hao Z., Gerrard T.L., Wilson Y.A., Johns D.G., Broder S. Inhibition of human immunodeficiency virus (HIV-I/HTLV-III Ba-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2′,3′-dideoxynucleosides. J. Exp. Med. 168:1988;1111-1125.
23. Perno C.F., Bergamini A., Pesce C.D., Milanese G., Capozzi M., Aquaro S., Thaisrivongs S., Tarpley W.G., Zon G., D'Agostini C., Rocchi G., Garci E., Caliò R. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages. J. Infect. Dis. 168:1993;1148-1156.
24. Perno C.F., Aquaro S., Rosenwirth B., Balestra E., Peichl P., Billich A., Villani N., Caliò R. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J. Leukoc. Biol. 56:1994;381-386.
25. Perno C.F., Newcomb F.M., Davis D.A., Aquaro S., Humphrey R.W., Caliò R., Yarchoan R. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J. Infect. Dis. 178:1998;413-422.
26. Roberts N.A., Martin J.A., Kinchington D., Broadhurst A.V., Craig J.C., Duncan I.B., Galpin S.A., Handa B.K., Kay J., Krohn A. Rational design of peptide-based HIV proteinase inhibitors. Science. 248:1990;358-361.
27. Sadler B.M., Hanson C.D., Chittick G.E., Symonds W.T., Roskell N.S. Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults. Antimicrob. Agents Chemother. 43:1999;1686-1692.
28. St. Clair M.H., Millard J., Rooney J., Tisdale M., Parry N., Sadler B.M., Blum M.R., Painter G. In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents. Antiviral Res. 29:1996;53-56.
29. Tyor W.R., Power C., Gendelman H.E., Markham R.B. A model of human immunodeficiency virus encephalitis in SCID mice. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8658-8662.